Celebrating 30 years of Thommen Implant System in Copenhagen

By Dental Tribune International

Sun. 5. June 2016

share

save

COPENHAGEN, Denmark: At this year’s European Academy of Esthetic Dentistry (EAED) meeting in Copenhagen, held from 2 to 4 June, Swiss implant manufacturer Thommen Medical showcased its popular implant–abutment connection, which marks its 30th anniversary this year. In addition, the manufacturer presented INICELL, an advancement of Thommen’s sandblasted and thermal acid-etched implant surface that has been proven to accelerate angiogenesis, a crucial precondition for fast osseointegration, in a recent ETH Zurich study.

Pursuing such qualities as Swiss precision, innovation and functional design, the company is celebrating 30 years of clinical experience and success with the Thommen implant–abutment connection this year. According to the company, the connection combines the essential features of an ideal implant–abutment interface—a stabilisation ring and internal hexagon—thus ensuring optimal mechanical stability with a highly precise fit.

For Thommen Medical International Marketing Director Gerald Barth, the EAED meeting was the ideal platform for exhibiting the company’s products to a specialist audience. “Here in Copenhagen, implantologists of distinction gather to exchange the latest trends and clinical results in a casual setting. That’s networking at its best,” Barth told Dental Tribune Online.

Furthermore, with INICELL, the company presented its clinically approved titanium implant surface. In a recent study, researchers at ETH Zurich found that INICELL upregulated the secretion of major factors associated with rapid healing, including matrix metalloproteinases, which break down the extracellular matrix, and vascular endothelial growth factor, which is known for its angiogenic capacity.

As sufficient blood supply is a precondition for new bone formation and consequently fast osseointegration, the research results demonstrate the potential of the INICELL implant surface for rapid and sustained integration of implants into bone, the company stated.

The results of the study, titled “Synergistic interactions of blood-borne immune cells, fibroblasts and extracellular matrix drive repair in an in vitro peri-implant wound healing model”, were published online on 17 February in the Scientific Reports journal.

More information about the company and its implant solutions can be found at www.thommenmedical.com.